Literature DB >> 22250239

Consensus guidelines for the management of plaque psoriasis.

Sylvia Hsu1, Kim Alexander Papp, Mark G Lebwohl, Jerry Bagel, Andrew Blauvelt, Kristina Callis Duffin, Jeffrey Crowley, Lawrence F Eichenfield, Steven R Feldman, David F Fiorentino, Joel M Gelfand, Alice B Gottlieb, Carmen Jacobsen, Robert E Kalb, Arthur Kavanaugh, Neil J Korman, Gerald G Krueger, Melissa A Michelon, Warwick Morison, Christopher T Ritchlin, Linda Stein Gold, Stephen P Stone, Bruce E Strober, Abby S Van Voorhees, Stefan C Weiss, Karolyn Wanat, Bruce F Bebo.   

Abstract

The Canadian Guidelines for the Management of Plaque Psoriasis were reviewed by the entire National Psoriasis Foundation Medical Board and updated to include newly approved agents such as ustekinumab and to reflect practice patterns in the United States, where the excimer laser is approved for psoriasis treatment. Management of psoriasis in special populations is discussed. In the updated guidelines, we include sections on children, pregnant patients or pregnant partners of patients, nursing mothers, the elderly, patients with hepatitis B or C virus infections, human immunodeficiency virus-infected patients, and patients with malignant neoplasms, as well as sections on tumor necrosis factor blockers, elective surgery, and vaccinations.

Entities:  

Mesh:

Year:  2012        PMID: 22250239     DOI: 10.1001/archdermatol.2011.1410

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  28 in total

1.  Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.

Authors:  Mehdi Rashighi; John E Harris
Journal:  Ann Transl Med       Date:  2015-12

2.  Secukinumab.

Authors:  Dennis J Cada; Danial E Baker; Shannon G Panther; Kyle Ingram PharmD
Journal:  Hosp Pharm       Date:  2015-09-16

3.  [Phototherapy in the era of biologicals].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2013-05       Impact factor: 0.751

Review 4.  Remicade® (infliximab): 20 years of contributions to science and medicine.

Authors:  Richard Melsheimer; Anja Geldhof; Isabel Apaolaza; Thomas Schaible
Journal:  Biologics       Date:  2019-07-30

Review 5.  Management of psoriasis patients with hepatitis B or hepatitis C virus infection.

Authors:  Claudio Bonifati; Viviana Lora; Dario Graceffa; Lorenzo Nosotti
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 6.  Atherosclerosis in psoriatic disease: latest evidence and clinical implications.

Authors:  Lihi Eder; Dafna D Gladman
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

Review 7.  Making the next steps in psoriatic arthritis management: current status and future directions.

Authors:  Diviya Sritheran; Ying Ying Leung
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

8.  More Biologic Therapies Expected To Treat Advanced Plaque Psoriasis.

Authors:  Chris Fellner
Journal:  P T       Date:  2016-06

Review 9.  Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: Prevention and Diagnosis.

Authors:  Ajay Premkumar; Kyle Morse; Ashley E Levack; Mathias P Bostrom; Alberto V Carli
Journal:  Curr Rheumatol Rep       Date:  2018-09-10       Impact factor: 4.592

10.  Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis.

Authors:  Vicky Ren; Harry Dao
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.